Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor

Surgery is the standard treatment for a primary gastrointestinal stromal tumor (GIST); however, surgical resection is often not curative, particularly for large GISTs. In the past decade, with imatinib mesylate (IM), management strategies for GISTs have evolved significantly, and now IM is the stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Kyu Jong, Kim, Nam Kyu, Lee, Kang Young, Min, Byung Soh, Hur, Hyuk, Kang, Jeonghyun, Lee, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Coloproctology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145886/
https://www.ncbi.nlm.nih.gov/pubmed/21829770
http://dx.doi.org/10.3393/jksc.2011.27.3.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145886/
https://www.ncbi.nlm.nih.gov/pubmed/21829770
http://dx.doi.org/10.3393/jksc.2011.27.3.147

Ejemplares similares